Found: 11
Select item for more details and to access through your institution.
Treatment and Long-Term Safety Outcomes of Peptide Receptor Radionuclide Therapy for Metastatic Neuroendocrine Tumours: An Asian Experience.
- Published in:
- Neuroendocrinology, 2024, v. 114, n. 9, p. 840, doi. 10.1159/000538523
- By:
- Publication type:
- Article
Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 3, p. 312, doi. 10.1111/ajco.13837
- By:
- Publication type:
- Article
Real‐world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian Center.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2021, v. 17, n. 5, p. e249, doi. 10.1111/ajco.13454
- By:
- Publication type:
- Article
What is the value of third‐line chemotherapy in advanced gastroesophageal cancer? A 5‐year retrospective analysis at a single center.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2020, v. 16, n. 1, p. 23, doi. 10.1111/ajco.13285
- By:
- Publication type:
- Article
Metastatic gastric cancer: Does the site of metastasis make a difference?
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 1, p. 10, doi. 10.1111/ajco.13025
- By:
- Publication type:
- Article
Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 1, p. 185, doi. 10.4143/crt.2015.497
- By:
- Publication type:
- Article
Inferring cancer disease response from radiology reports using large language models with data augmentation and prompting.
- Published in:
- Journal of the American Medical Informatics Association, 2023, v. 30, n. 10, p. 1657, doi. 10.1093/jamia/ocad133
- By:
- Publication type:
- Article
First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 7, doi. 10.1159/000526639
- By:
- Publication type:
- Article
Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 1, p. 9, doi. 10.1159/000518619
- By:
- Publication type:
- Article
Metabolomic prediction of treatment outcome in pancreatic ductal adenocarcinoma patients receiving gemcitabine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2018, v. 81, n. 2, p. 277, doi. 10.1007/s00280-017-3475-6
- By:
- Publication type:
- Article
Metabolomic prediction of treatment outcome in pancreatic ductal adenocarcinoma patients receiving gemcitabine.
- Published in:
- 2017
- By:
- Publication type:
- journal article